NCT07214961
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07214961
Title Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (ARTISAN)
Acronym ARTISAN
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors ARTBIO Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.